{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T23:40:10Z","timestamp":1782258010710,"version":"3.54.5"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s00774-025-01641-8","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T17:43:13Z","timestamp":1759513393000},"page":"662-671","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["One-year bone mineral density gains with anti-osteoporotic medications and clinical factors associated with non-BMD gainers"],"prefix":"10.1007","volume":"43","author":[{"given":"Seol A","family":"Jang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok-Jae","family":"Heo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Jin","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul Sik","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok Won","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8150-0266","authenticated-orcid":false,"given":"Kyoung Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"key":"1641_CR1","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5152\/eurjrheum.2016.048","volume":"4","author":"T S\u00f6zen","year":"2016","unstructured":"S\u00f6zen T, \u00d6z\u0131\u015f\u0131k L, Ba\u015faran N\u00c7 (2016) An overview and management of osteoporosis. Eur J Rheumatol 4:46","journal-title":"Eur J Rheumatol"},{"key":"1641_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.bone.2011.04.022","volume":"49","author":"RGG Russell","year":"2011","unstructured":"Russell RGG (2011) Bisphosphonates: the first 40 years. Bone 49:2\u201319","journal-title":"Bone"},{"key":"1641_CR3","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1210\/clinem\/dgaa048","volume":"105","author":"D Shoback","year":"2020","unstructured":"Shoback D, Rosen CJ, Black DM, Cheung AM, Murad MH, Eastell R (2020) Pharmacological management of osteoporosis in postmenopausal women: an endocrine society guideline update. J Clin Endocrinol Metab 105:587\u2013594","journal-title":"J Clin Endocrinol Metab"},{"key":"1641_CR4","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","volume":"344","author":"RM Neer","year":"2001","unstructured":"Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster J-Y, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK (2001) Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434\u20131441","journal-title":"N Engl J Med"},{"key":"1641_CR5","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","volume":"375","author":"F Cosman","year":"2016","unstructured":"Cosman F, Crittenden DB, Adachi JD, Binkley N, Czerwinski E, Ferrari S, Hofbauer LC, Lau E, Lewiecki EM, Miyauchi A (2016) Romosozumab treatment in postmenopausal women with osteoporosis. N Engl J Med 375:1532\u20131543","journal-title":"N Engl J Med"},{"key":"1641_CR6","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1007\/s00198-012-2093-8","volume":"23","author":"A Diez-Perez","year":"2012","unstructured":"Diez-Perez A, Adachi J, Agnusdei D, Bilezikian J, Compston J, Cummings S, Eastell R, Eriksen E, Gonzalez-Macias J, Liberman U (2012) Treatment failure in osteoporosis. Osteoporos Int 23:2769\u20132774","journal-title":"Osteoporos Int"},{"key":"1641_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.52628\/89.1.9808","volume":"89","author":"S Kim","year":"2023","unstructured":"Kim S, Lee D (2023) A retrospective analysis of nonresponse to denosumab after hip fractures. Acta Orthop Belg 89:71\u201376","journal-title":"Acta Orthop Belg"},{"key":"1641_CR8","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s00774-023-01412-3","volume":"41","author":"G Anna","year":"2023","unstructured":"Anna G, Anne-Lise F, Clemence D, Jean-Michel P, Florence T (2023) Factors associated with bone response to teriparatide in young postmenopausal women with osteoporosis. J Bone Miner Metab 41:278\u2013285. https:\/\/doi.org\/10.1007\/s00774-023-01412-3","journal-title":"J Bone Miner Metab"},{"key":"1641_CR9","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1007\/s001980070002","volume":"11","author":"P Delmas","year":"2000","unstructured":"Delmas P, Eastell R, Garnero P, Seibel M, Stepan J, CoSAotIO F (2000) The use of biochemical markers of bone turnover in osteoporosis. Osteoporos Int 11:S2","journal-title":"Osteoporos Int"},{"key":"1641_CR10","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1007\/s00198-016-3581-z","volume":"27","author":"R Niimi","year":"2016","unstructured":"Niimi R, Kono T, Nishihara A, Hasegawa M, Kono T, Sudo A (2016) A retrospective analysis of nonresponse to daily teriparatide treatment. Osteoporos Int 27:2845\u20132853","journal-title":"Osteoporos Int"},{"key":"1641_CR11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.bone.2018.10.015","volume":"120","author":"P Miller","year":"2019","unstructured":"Miller P, Hattersley G, Lau E, Fitzpatrick L, Harris A, Williams G, Hu M-Y, Riis B, Russo L, Christiansen C (2019) Bone mineral density response rates are greater in patients treated with abaloparatide compared with those treated with placebo or teriparatide: results from the ACTIVE phase 3 trial. Bone 120:137\u2013140","journal-title":"Bone"},{"key":"1641_CR12","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.bone.2006.06.007","volume":"39","author":"JC Gallagher","year":"2006","unstructured":"Gallagher JC, Rosen C, Chen P, Misurski D, Marcus R (2006) Response rate of bone mineral density to teriparatide in postmenopausal women with osteoporosis. Bone 39:1268\u20131275","journal-title":"Bone"},{"key":"1641_CR13","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.clinthera.2008.03.008","volume":"30","author":"AI Sebba","year":"2008","unstructured":"Sebba AI (2008) Significance of a decline in bone mineral density while receiving oral bisphosphonate treatment. Clin Ther 30:443\u2013452","journal-title":"Clin Ther"},{"key":"1641_CR14","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1210\/clinem\/dgz163","volume":"105","author":"SK Ramchand","year":"2020","unstructured":"Ramchand SK, David NL, Leder BZ, Tsai JN (2020) Bone mineral density response with denosumab in combination with standard or high-dose teriparatide: the DATA-HD RCT. J Clin Endocrinol Metab 105:890\u2013897","journal-title":"J Clin Endocrinol Metab"},{"key":"1641_CR15","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.eprac.2023.04.011","volume":"29","author":"DE Powell","year":"2023","unstructured":"Powell DE, Evans SF, Rakieh C (2023) Bone mineral density response to long-term bisphosphonate treatment and discontinuation in a real-world clinical service. Endocr Pract 29:601\u2013605. https:\/\/doi.org\/10.1016\/j.eprac.2023.04.011","journal-title":"Endocr Pract"},{"key":"1641_CR16","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","volume":"377","author":"KG Saag","year":"2017","unstructured":"Saag KG, Petersen J, Brandi ML, Karaplis AC, Lorentzon M, Thomas T, Maddox J, Fan M, Meisner PD, Grauer A (2017) Romosozumab or alendronate for fracture prevention in women with osteoporosis. N Engl J Med 377:1417\u20131427","journal-title":"N Engl J Med"},{"key":"1641_CR17","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/jbmr\/zjae194","volume":"40","author":"MR McClung","year":"2025","unstructured":"McClung MR, Betah D, Leder BZ, Kendler DL, Oates M, Timoshanko J, Wang Z (2025) Romosozumab improves microarchitecture as assessed by tissue thickness\u2013adjusted trabecular bone score in postmenopausal women with osteoporosis. J Bone Miner Res 40:193\u2013200","journal-title":"J Bone Miner Res"},{"key":"1641_CR18","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJMoa0809493","volume":"361","author":"SR Cummings","year":"2009","unstructured":"Cummings SR, Martin JS, McClung MR, Siris ES, Eastell R, Reid IR, Delmas P, Zoog HB, Austin M, Wang A (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361:756\u2013765","journal-title":"N Engl J Med"},{"key":"1641_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bonr.2020.100275","volume":"12","author":"T Mawatari","year":"2020","unstructured":"Mawatari T, Ikemura S, Matsui G, Iguchi T, Mitsuyasu H, Kawahara S, Maehara M, Muraoka R, Iwamoto Y, Nakashima Y (2020) Assessment of baseline bone turnover marker levels and response to risedronate treatment: data from a Japanese phase III trial. Bone Rep 12:100275. https:\/\/doi.org\/10.1016\/j.bonr.2020.100275","journal-title":"Bone Rep"},{"key":"1641_CR20","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s00223-021-00930-4","volume":"112","author":"SD Vasikaran","year":"2023","unstructured":"Vasikaran SD, Miura M, Pikner R, Bhattoa HP, Cavalier E, Metabolism I-IJCoB (2023) Practical considerations for the clinical application of bone turnover markers in osteoporosis. Calcif Tissue Int 112:148\u2013157","journal-title":"Calcif Tissue Int"},{"key":"1641_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-025-07422-3","author":"HP Bhattoa","year":"2025","unstructured":"Bhattoa HP, Vasikaran S, Trifonidi I, Kapoula G, Lombardi G, J\u00f8rgensen NR, Pikner R, Miura M, Chapurlat R, Hiligsmann M (2025) Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), International Osteoporosis Foundation (IOF), and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). Osteoporos Int. https:\/\/doi.org\/10.1007\/s00198-025-07422-3","journal-title":"Osteoporos Int"},{"key":"1641_CR22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1210\/endrev\/bnac031","volume":"44","author":"M Schini","year":"2023","unstructured":"Schini M, Vilaca T, Gossiel F, Salam S, Eastell R (2023) Bone turnover markers: basic biology to clinical applications. Endocr Rev 44:417\u2013473","journal-title":"Endocr Rev"},{"key":"1641_CR23","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1093\/mr\/roae008","volume":"34","author":"K Hattori","year":"2024","unstructured":"Hattori K, Kanayama Y (2024) Association between P1NP value and increases in bone mineral density in patients with postmenopausal osteoporosis treated with romosozumab. Mod Rheumatol 34:1047\u20131055","journal-title":"Mod Rheumatol"},{"key":"1641_CR24","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00198-014-2860-9","volume":"26","author":"L Seguro","year":"2015","unstructured":"Seguro L, Casella C, Caparbo V, Oliveira R, Bonfa A, Bonfa E, Pereira R (2015) Lower P1NP serum levels: a predictive marker of bone loss after 1 year follow-up in premenopausal systemic lupus erythematosus patients. Osteoporos Int 26:459\u2013467","journal-title":"Osteoporos Int"},{"key":"1641_CR25","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/S0140-6736(18)32112-3","volume":"393","author":"JE Compston","year":"2019","unstructured":"Compston JE, McClung MR, Leslie WD (2019) Osteoporosis. Lancet 393:364\u2013376. https:\/\/doi.org\/10.1016\/S0140-6736(18)32112-3","journal-title":"Lancet"},{"key":"1641_CR26","doi-asserted-by":"crossref","unstructured":"Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A (2018) Inflammaging: a new immune\u2013metabolic viewpoint for age-related diseases. Nat Rev Endocrinol 14:576\u2013590.","DOI":"10.1038\/s41574-018-0059-4"},{"key":"1641_CR27","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1093\/jbmr\/zjae068","volume":"39","author":"M Schini","year":"2024","unstructured":"Schini M, Vilaca T, Lui LY, Ewing SK, Thompson A, Vittinghoff E, Bauer DC, Bouxsein ML, Black DM, Eastell R (2024) Pre-treatment bone mineral density and the benefit of pharmacologic treatment on fracture risk and BMD change: analysis from the FNIH-ASBMR SABRE project. J Bone Miner Res 39:867\u2013876. https:\/\/doi.org\/10.1093\/jbmr\/zjae068","journal-title":"J Bone Miner Res"},{"key":"1641_CR28","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1007\/s00198-017-3923-5","volume":"28","author":"M Kamimura","year":"2017","unstructured":"Kamimura M, Nakamura Y, Ikegami S, Uchiyama S, Kato H, Taguchi A (2017) Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients: response to comments. Osteoporos Int 28:1757\u20131758. https:\/\/doi.org\/10.1007\/s00198-017-3923-5","journal-title":"Osteoporos Int"},{"key":"1641_CR29","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jsbmb.2013.12.011","volume":"142","author":"JV Pinkerton","year":"2014","unstructured":"Pinkerton JV, Thomas S (2014) Use of SERMs for treatment in postmenopausal women. J Steroid Biochem Mol Biol 142:142\u2013154","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1641_CR30","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1210\/clinem\/dgad496","volume":"109","author":"SK Ramchand","year":"2024","unstructured":"Ramchand SK, Leder BZ (2024) Sequential therapy for the long-term treatment of postmenopausal osteoporosis. J Clin Endocrinol Metab 109:303\u2013311","journal-title":"J Clin Endocrinol Metab"},{"key":"1641_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115516","volume":"139","author":"B Langdahl","year":"2020","unstructured":"Langdahl B (2020) Treatment of postmenopausal osteoporosis with bone-forming and antiresorptive treatments: combined and sequential approaches. Bone 139:115516","journal-title":"Bone"},{"key":"1641_CR32","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1007\/s00774-021-01226-1","volume":"39","author":"T Shimizu","year":"2021","unstructured":"Shimizu T, Arita K, Murota E, Hiratsuka S, Fujita R, Ishizu H, Asano T, Takahashi D, Takahata M, Iwasaki N (2021) Effects after starting or switching from bisphosphonate to romosozumab or denosumab in Japanese postmenopausal patients. J Bone Miner Metab 39:868\u2013875","journal-title":"J Bone Miner Metab"},{"key":"1641_CR33","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.bonr.2018.03.006","volume":"8","author":"T Suzuki","year":"2018","unstructured":"Suzuki T, Nakamura Y, Kamimura M, Kato H (2018) Denosumab significantly improves lumbar spine bone mineral density more in treatment-na\u00efve than in long-term bisphosphonate-treated patients. Bone Rep 8:110\u2013114","journal-title":"Bone Rep"},{"key":"1641_CR34","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/jbmr.3051","volume":"32","author":"F Cosman","year":"2017","unstructured":"Cosman F, Nieves JW, Dempster DW (2017) Treatment sequence matters: anabolic and antiresorptive therapy for osteoporosis. J Bone Miner Res 32:198\u2013202","journal-title":"J Bone Miner Res"},{"key":"1641_CR35","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1007\/s00198-021-06174-0","volume":"33","author":"F Cosman","year":"2022","unstructured":"Cosman F, Kendler DL, Langdahl BL, Leder BZ, Lewiecki EM, Miyauchi A, Rojeski M, McDermott M, Oates MK, Milmont CE (2022) Romosozumab and antiresorptive treatment: the importance of treatment sequence. Osteoporos Int 33:1243\u20131256","journal-title":"Osteoporos Int"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-025-01641-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00774-025-01641-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-025-01641-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T00:37:58Z","timestamp":1767487078000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00774-025-01641-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["1641"],"URL":"https:\/\/doi.org\/10.1007\/s00774-025-01641-8","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"26 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}